The news is by your side.
Browsing Tag


Facing rival drugs, Novartis gets win with Afinitor in Europe

2 years, 4 months ago
LONDON: Efforts by Novartis to defend its blockbuster cancer drug Afinitor against competitors got a boost on Thursday from European regulators, who approved it for use on certain types of advanced gastrointestinal and lung neuroendocrine…